BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 34768915)

  • 1. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
    Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Liu X; Song M; Wang P; Zhao R; Chen H; Zhang M; Shi Y; Liu K; Liu F; Yang R; Li E; Bode AM; Dong Z; Lee MH
    Int J Cancer; 2019 Aug; 145(4):1007-1019. PubMed ID: 30887517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Borneol Enhances Paclitaxel-Induced Apoptosis of ESCC Cells by Inactivation of the PI3K/AKT.
    Meng X; Dong X; Wang W; Yang L; Zhang X; Li Y; Chen T; Ma H; Qi D; Su J
    J Food Sci; 2018 May; 83(5):1436-1443. PubMed ID: 29660811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade.
    Jin H; Park MH; Kim SM
    Oncol Rep; 2015 Apr; 33(4):2031-6. PubMed ID: 25633416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the Akt/FOXM1 Signaling Pathway by Panobinostat Suppresses the Proliferation and Metastasis of Gastric Cancer Cells.
    Lee NR; Kim DY; Jin H; Meng R; Chae OH; Kim SH; Park BH; Kim SM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt.
    Lee HH; Ye S; Li XJ; Lee KB; Park MH; Kim SM
    Oncol Rep; 2014 Jan; 31(1):183-8. PubMed ID: 24247637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
    Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
    Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
    Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
    Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway.
    Chang Y; Jia HQ; Xu B; Yang L; Xu YT; Zhang JY; Wang MQ; Yang LX; Song ZC
    Chem Biol Drug Des; 2024 Jan; 103(1):e14416. PubMed ID: 38093418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capilliposide C Sensitizes Esophageal Squamous Carcinoma Cells to Oxaliplatin by Inducing Apoptosis Through the PI3K/Akt/mTOR Pathway.
    Shen Z; Xu L; Li J; Zhang N
    Med Sci Monit; 2017 May; 23():2096-2103. PubMed ID: 28463955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway.
    Lu YX; Chen DL; Wang DS; Chen LZ; Mo HY; Sheng H; Bai L; Wu QN; Yu HE; Xie D; Yun JP; Zeng ZL; Wang F; Ju HQ; Xu RH
    Cell Death Dis; 2016 Oct; 7(10):e2432. PubMed ID: 27787516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive Oxygen Species-Mediated Autophagy by Ursolic Acid Inhibits Growth and Metastasis of Esophageal Cancer Cells.
    Lee NR; Meng RY; Rah SY; Jin H; Ray N; Kim SH; Park BH; Kim SM
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
    Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
    Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway.
    Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F
    Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
    Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
    Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells.
    Kwak AW; Lee MJ; Lee MH; Yoon G; Cho SS; Chae JI; Shim JH
    Phytomedicine; 2021 Jun; 86():153564. PubMed ID: 33895649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma.
    Liu F; Zu X; Xie X; Zhang Y; Liu K; Chen H; Wang T; Bode AM; Dong Z; Kim DJ
    Cancer Prev Res (Phila); 2019 Dec; 12(12):849-860. PubMed ID: 31554627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.